Literature DB >> 11263589

Risk of breast cancer in relation to anthropometry, blood pressure, blood lipids and glucose metabolism: a prospective study within the Malmö Preventive Project.

J Manjer1, R Kaaks, E Riboli, G Berglund.   

Abstract

Insulin resistance may be a risk factor for breast cancer, possibly through increased levels of oestrogens or insulin-like growth factor I. Insulin resistance has been associated with obesity, hypertension, dyslipidaemia and impaired glucose tolerance. We studied the relation of these factors to breast cancer risk in a prospective cohort study of 9738 women. Menopausal status was defined a priori, and 112 cases of invasive breast carcinoma occurred in women who were premenopausal at baseline and 157 cases in subjects who were peri/postmenopausal. Relative risks (RR) for breast cancer were calculated by Cox's proportional hazards analysis for different quartiles of height, weight, body mass index, blood pressure, pulse rate and serum levels of total cholesterol, triglycerides, fasting blood glucose and glucose at 120 min after an oral dose of glucose. Peri/postmenopausal women had a significantly increased age-adjusted relative risk of breast cancer associated with height (RR = 1.78 for the highest versus lowest quartile), and the RR was increased over quartiles of cholesterol levels (P-value for trend: 0.05). No other significant associations were found. Adjustments for potential confounding factors or restriction of the analysis to cases and person-years before 55 years of age (premenopausal women), or after 55 years (peri/postmenopausal women), did not change

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11263589     DOI: 10.1097/00008469-200102000-00004

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  20 in total

1.  A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer.

Authors:  Geoffrey C Kabat; Mimi Kim; Rowan T Chlebowski; Janu Khandekar; Marcia G Ko; Anne McTiernan; Marian L Neuhouser; Donna R Parker; James M Shikany; Marcia L Stefanick; Cynthia A Thomson; Thomas E Rohan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06-30       Impact factor: 4.254

Review 2.  Blood glucose concentrations and breast cancer risk in women without diabetes: a meta-analysis.

Authors:  Peter Boyle; Alice Koechlin; Cécile Pizot; Mathieu Boniol; Chris Robertson; Patrick Mullie; Geremia Bolli; Julio Rosenstock; Philippe Autier
Journal:  Eur J Nutr       Date:  2012-11-03       Impact factor: 5.614

Review 3.  Insulin and IGFs in obesity-related breast cancer.

Authors:  Valentina Belardi; Emily J Gallagher; Ruslan Novosyadlyy; Derek LeRoith
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-10-24       Impact factor: 2.673

4.  Long-term temporal trends in cardiovascular and metabolic risk factors.

Authors:  Wegene Borena; Tanja Stocks; Susanne Strohmaier; Alexander Strasak; Jonas Manjer; Dorthe Johansen; Håkan Jonsson; Kilian Rapp; Hans Concin; Göran Hallmans; Pär Stattin; Hanno Ulmer
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

5.  Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria.

Authors:  K Rapp; J Schroeder; J Klenk; H Ulmer; H Concin; G Diem; W Oberaigner; S K Weiland
Journal:  Diabetologia       Date:  2006-03-24       Impact factor: 10.122

6.  Association of cancer with moderately impaired renal function at baseline in a large, representative, population-based cohort followed for up to 30 years.

Authors:  Anders Christensson; Caroline Savage; Daniel D Sjoberg; Angel M Cronin; M Frank O'Brien; William Lowrance; Peter M Nilsson; Andrew J Vickers; Paul Russo; Hans Lilja
Journal:  Int J Cancer       Date:  2013-03-29       Impact factor: 7.396

7.  Metabolic syndrome and outcomes following early-stage breast cancer.

Authors:  Gregory S Calip; Kathleen E Malone; Julie R Gralow; Andy Stergachis; Rebecca A Hubbard; Denise M Boudreau
Journal:  Breast Cancer Res Treat       Date:  2014-10-10       Impact factor: 4.872

Review 8.  Cancer Progress and Priorities: Breast Cancer.

Authors:  Serena C Houghton; Susan E Hankinson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-05       Impact factor: 4.090

9.  Targeting of PP2Cδ By a Small Molecule C23 Inhibits High Glucose-Induced Breast Cancer Progression In Vivo.

Authors:  Ke Wu; Xiaoting Yu; Zhimin Huang; Donghui Zhu; Xianghua Yi; Ying-Li Wu; Qiongyu Hao; Kevin T Kemp; Yahya Elshimali; Roshni Iyer; Kytai Truong Nguyen; Shilong Zheng; Guanglin Chen; Qiao-Hong Chen; Guangdi Wang; Jaydutt V Vadgama; Yong Wu
Journal:  Antioxid Redox Signal       Date:  2018-07-13       Impact factor: 7.468

10.  Biomarkers of the metabolic syndrome and breast cancer prognosis.

Authors:  Qiu-Li Zhu; Wang-Hong Xu; Meng-Hua Tao
Journal:  Cancers (Basel)       Date:  2010-04-28       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.